Trials / Terminated
TerminatedNCT00803868
Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if varenicline is effective in treating symptoms of Friedreich's ataxia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | varenicline | up to 1mg po bid for 9 weeks |
| DRUG | placebo | placebo matching study drug up to 1mg po bid |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2008-12-08
- Last updated
- 2012-07-24
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00803868. Inclusion in this directory is not an endorsement.